SVRA - Savara Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Austin,
United States
Type: Equity
SVRA price evolution
SVRA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $23.86 | $16.79 | $26.59 | |
| Short term investments | $97.65 | $126.26 | $135.73 | |
| Net receivables | $1.16 | $1.02 | $0.94 | $1 |
| Inventory | ||||
| Total current assets | $226.4 | $127.69 | $146.19 | $165.95 |
| Long term investments | ||||
| Property, plant & equipment | $0.21 | $0.24 | $0.25 | $0.27 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $11.98 | $12.11 | $11.62 | |
| Total investments | $97.65 | $126.26 | $135.73 | |
| Total assets | $238.82 | $139.67 | $158.29 | $177.56 |
| Current liabilities | ||||
| Accounts payable | $4.61 | $3.39 | $2.85 | $3.5 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $12.79 | $11.29 | $9.81 | $10.6 |
| Long term debt | $26.55 | $26.48 | $26.42 | $26.35 |
| Total noncurrent liabilities | $26.65 | $26.62 | $26.59 | |
| Total debt | $26.48 | $26.42 | $26.35 | |
| Total liabilities | $39.47 | $37.94 | $36.43 | $37.19 |
| Shareholders' equity | ||||
| Retained earnings | -$460.21 | -$435.96 | -$413.71 | -$393.37 |
| Other shareholder equity | -$0.2 | -$0.88 | -$0.74 | -$0.27 |
| Total shareholder equity | $101.73 | $121.86 | $140.37 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26.59 | $52.1 | $34.01 | $22.88 |
| Short term investments | $135.73 | $73.78 | $127.16 | $59.31 |
| Net receivables | $1 | $0.95 | $1.14 | $1.7 |
| Inventory | ||||
| Total current assets | $165.95 | $128.95 | $165 | $85.1 |
| Long term investments | ||||
| Property, plant & equipment | $0.27 | $0.15 | $0.37 | $0.4 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $11.62 | $10.82 | $11.6 | $12.62 |
| Total investments | $135.73 | $73.78 | $127.16 | $59.31 |
| Total assets | $177.56 | $139.78 | $176.6 | $97.7 |
| Current liabilities | ||||
| Accounts payable | $3.5 | $1.33 | $1.44 | $2.6 |
| Deferred revenue | ||||
| Short long term debt | $8.33 | |||
| Total current liabilities | $10.6 | $5.87 | $14.66 | $8.2 |
| Long term debt | $26.35 | $26.08 | $17.32 | $25.1 |
| Total noncurrent liabilities | $26.59 | $26.13 | $17.44 | $25.19 |
| Total debt | $26.35 | $26.08 | $25.66 | $25.1 |
| Total liabilities | $37.19 | $32 | $32.1 | $33.4 |
| Shareholders' equity | ||||
| Retained earnings | -$393.37 | -$338.67 | -$300.52 | -$257.5 |
| Other shareholder equity | -$0.27 | -$0.59 | $0.05 | $0.9 |
| Total shareholder equity | $140.37 | $107.78 | $144.5 | $64.38 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $17.62 | $16.81 | $12.75 | |
| Selling, general & administrative | $5.54 | $5.64 | $4.85 | |
| Total operating expenses | $26.36 | $23.19 | $22.48 | $17.63 |
| Operating income | -$23.19 | -$22.48 | -$17.63 | |
| Income from continuing operations | ||||
| EBIT | -$22.24 | -$20.35 | -$14.58 | |
| Income tax expense | ||||
| Interest expense | $2.11 | $1.52 | ||
| Net income | ||||
| Net income | -$24.25 | -$22.24 | -$20.35 | -$16.1 |
| Income (for common shares) | -$22.24 | -$20.35 | -$16.1 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.26 | |||
| Cost of revenue | ||||
| Gross Profit | $0.26 | |||
| Operating activities | ||||
| Research & development | $44.26 | $27.88 | $28.99 | $35.04 |
| Selling, general & administrative | $15.67 | $10.93 | $12.35 | $14.26 |
| Total operating expenses | $60.01 | $38.84 | $41.48 | $49.56 |
| Operating income | -$60.01 | -$38.84 | -$41.48 | -$49.3 |
| Income from continuing operations | ||||
| EBIT | -$50.26 | -$38.06 | -$40.73 | -$48.13 |
| Income tax expense | ||||
| Interest expense | $4.44 | $0.09 | $2.28 | $1.48 |
| Net income | ||||
| Net income | -$54.7 | -$38.15 | -$43.01 | -$49.62 |
| Income (for common shares) | -$54.7 | -$38.15 | -$43.01 | -$49.62 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$22.24 | -$20.35 | -$16.1 | |
| Operating activities | ||||
| Depreciation | $0.07 | $0.07 | $0.07 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.2 | $2.26 | $1.36 | |
| Total cash flows from operations | -$22.5 | -$20.64 | -$15.6 | |
| Investing activities | ||||
| Capital expenditures | -$0.02 | -$0.01 | -$0.02 | |
| Investments | $29.56 | $10.8 | $6.59 | |
| Total cash flows from investing | -$57.84 | $29.54 | $10.79 | $6.57 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | $0.05 | $8.92 | |
| Net borrowings | ||||
| Total cash flows from financing | $118.42 | $0.06 | $0.05 | $7.89 |
| Effect of exchange rate | $0.07 | -$0.02 | $0 | $0.03 |
| Change in cash and equivalents | -$5.16 | $7.08 | -$9.8 | -$1.1 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$54.7 | -$38.15 | -$43.01 | -$49.62 |
| Operating activities | ||||
| Depreciation | $0.17 | $0.17 | $0.37 | $0.69 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.18 | $2.04 | $3.26 | $5.11 |
| Total cash flows from operations | -$51.06 | -$34.55 | -$40.08 | -$39.84 |
| Investing activities | ||||
| Capital expenditures | -$0.3 | -$0.01 | -$0.06 | -$0.05 |
| Investments | -$56.82 | $52.65 | -$69.4 | $12.35 |
| Total cash flows from investing | -$57.12 | $52.65 | -$69.46 | $9.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $83.99 | $0 | $124.79 | $4.2 |
| Net borrowings | $0.09 | -$0.51 | ||
| Total cash flows from financing | $82.78 | $0.09 | $120.81 | $3.69 |
| Effect of exchange rate | -$0.12 | -$0.09 | -$0.14 | $0.17 |
| Change in cash and equivalents | -$25.52 | $18.09 | $11.13 | -$26.92 |
News
Fundamentals
| Market cap | $734.62M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 170.84M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$82.94M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -8.86 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.49 |
|---|---|
| ROA | -46.44% |
| ROE | N/A |
| Debt/Equity | 0.26 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 17.70 |
| Quick ratio | N/A |